News

Pembrolizumab is marketed in the US under the name Keytruda. EAMS was introduced by the UK Medicines and Healthcare Products Regulatory Agency (MHRA) in 2014 to help patients

In October 2010, the Japanese firm entered into an agreement with the Japan Health HS Foundation for the development of the HPV vaccine to prevent cervical cancer. Subsequently,

Lpathomab is a new antibody targeting Lysophosphatidic Acid (LPA), a bioactive lipid that has been characterized in the scientific literature as playing a major role in nerve injury

Endo said it would pay $175 per Salix share, which will include 1.4607 of its shares plus $45 in cash. Earlier in February, Canada-based Valeant Pharmaceuticals signed an

The MAA is based on positive data from the Phase III MYRROR trial, which randomized 122 patients to receive either aflibercept solution 2mg or sham. The multi-center, double-masked,

Under the deal, InMed’s Intelligent Cannabinoid Drug Design Platform (IDP) will be used to identify cannabinoid- and non-cannabinoid-based phytochemicals for ocular therapies focused on reducing various pro-inflammatory cytokines

The drug is approved in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2 (IL-2), and 13-cis-retinoic acid (RA) in patients who achieve at least a partial response to prior

The open label single arm Phase II trial of PB272 monotherapy will involve a total of 70 patients with HER2-positive early stage breast cancer who have previously received

Temovate is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. The launch strengthens the company’s growing portfolio of valuable topical products and shows